Zafgen Obtains $21,000,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    1 Cambridge Center Cambridge, MA 02142
  • Company Description
    The company is developing novel therapeutics for the treatment of obesity.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds from the financing will be used to support the continued development of beloranib, the obesity therapeutic that is currently in phase 2a clinical development.
  • M&A Terms
  • Venture Investor
    Alta Partners
  • Venture Investor
    Atlas Venture
  • Venture Investor
    Third Rock Ventures

Trending on Xconomy